Business
Sanara MedTech Announces the Launch of BIAKŌS(TM) Antimicrobial Wound Gel As Well as Recent Viral Testing Results for BIAKŌS(TM) Skin and Wound Cleanser
FORT WORTH, TX / ACCESSWIRE / November 5, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara" or the "Company")
About this update from Sanara Medtech Inc.
[{"type":"text","content":"FORT WORTH, TX / ACCESSWIRE / November 5, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (\"Sanara\" or the \"Company\") (NASDAQ:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced the launch of BIAKŌS™ Antimicrobial Wound Gel as well as recent viral testing results for BIAKŌS™ Skin and Wound Cleanser.BIAKŌS™ Antimicrobial Wound Gel BIAKŌS™ Antimicrobial Wound Gel is an antimicrobial hydrogel wound dressing available from Sanara MedTech Inc. It can be used alone or in combination with BIAKŌS™ Antimicrobial Skin and Wound Cleanser. Based on laboratory studies, when used in conjunction the products can work together to enhance effectiveness. The cleanser is applied initially to clean a wound and disrupts biofilm microbes (removing 99% in 10 minutes). The gel can then be applied and will remain in the wound for up to 72 hours helping to continue to disrupt biofilm microbes.When used in clinical settings, BIAKŌS™ Antimicrobial Wound Gel is indicated for the management of partial and full-thickness wounds, such as diabetic foot ulcers, post-surgical wounds, pressure ulcers, first and second-degree burns, grafts and donor sites.Safety studies demonstrated that BIAKŌS™ is biocompatible and supports the wound healing process.BIAKŌS™ Antimicrobial Skin and Wound Cleanser Testing Results Against SARS-CoV-2Rochal Industries recently collaborated with the World Reference Center for Emerging Viruses and Arboviruses, at the University of Texas Medical Branch, Galveston, TX to further test BIAKŌS™ Antimicrobial Skin and Wound Cleanser's impact on Severe Acute Respiratory Syndrome Coronavirus 2 (\"SARS-CoV-2\"), the virus that causes Coronavirus Disease 2019 (\"COVID-19\"). Laboratory studies were performed to determine if BIAKŌS™ Antimicrobial Skin and Wound Cleanser could reduce viral loads on contact as well as after drying and remaining on the skin as a coating.Laboratory testing demonstrated that BIAKŌS™ Antimicrobial Skin and Wound Cleanser reduced SARS-CoV-2 viral loads during the application of the liquid cleanser and as a coating for up to four hours after application. Results using the liquid form of BIAKŌS™ showed a 98.4% reduction in viral load on a porcine skin explant after 30 seconds, and a 99.3% reduction after 10 minutes. During laboratory ...